Home > Product > API IntermediatesAPI Intermediates
Dasatinib Tablets
Product Name: Dasatinib Tablets
CAS NO.: 302962-49-8
Patent Maturity Time: No Patent
Application: Treat chronic myeloid leukemia (CML) with resistance or intolerance
to prior therapy including imatinib
Characteristic: New product in China.
Single impurity≤0.1%.
Mature production technology